Related Experiment Videos

LncRNA625 inhibits STAT1-mediated transactivation potential in esophageal cancer cells

Huang Guo-Wei1, Li Chun-Quan2, Liao Lian-Di3

  • 1Institute of Oncologic Pathology, Shantou University Medical College, Shantou, Guangdong, 515041, PR China; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shantou University Medical College, Shantou, Guangdong, 515041, PR China; Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, PR China.

Insights

Long non-coding RNA lncRNA625 inhibits Signal transducer and activator of transcription 1 (STAT1) activity in cancer. LncRNA625 promotes STAT1 dephosphorylation by forming complexes with TC45, reducing STAT1-mediated transcription.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • RNA Biology

Background:

  • Signal transducer and activator of transcription 1 (STAT1) activity is often inhibited in cancer cells, but the underlying mechanisms remain unclear.
  • Understanding how STAT1 activity is regulated is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the role of long non-coding RNA lncRNA625 in regulating STAT1 activity.
  • To elucidate the molecular mechanism by which lncRNA625 affects STAT1-mediated transcription.

Main Methods:

  • Quantitative real-time PCR to assess gene expression.
  • Reporter gene assays to measure STAT1 transcriptional activity.
  • Co-immunoprecipitation to study protein-protein interactions.
  • Western blotting to detect protein phosphorylation status.

Main Results:

  • Knockdown of lncRNA625 led to increased STAT1-mediated transcription and IFITM2 expression.
  • Upregulation of lncRNA625 inhibited STAT1 reporter activity.
  • LncRNA625 was found to inhibit STAT1 binding to the IFITM2 promoter.
  • LncRNA625 interacted with the DNA-binding domain of STAT1 and promoted its interaction with TC45, leading to pSTAT1 dephosphorylation.

Conclusions:

  • LncRNA625 acts as a negative regulator of STAT1 activity in cancer cells.
  • LncRNA625 inhibits STAT1-mediated transactivation by facilitating STAT1 dephosphorylation via the TC45 phosphatase.
  • This mechanism involves the formation of a STAT1-TC45 complex induced by lncRNA625.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K